Here is one of his releases from RichMark:
RICHMARK CAPITAL CORPORATION INITIATES COVERAGE
Story Filed: Wednesday, May 05, 1999 2:49 PM EST
on Cypros Pharmaceutical Corporation
LA JOLLA, Calif., May 5 /PRNewswire/ -- The following is being issued by RichMark Capital Corporation, a member of the
National Association of Securities Dealers, CRD number 43162:
RichMark Capital Corporation, an Investment Banking firíáeadquartered in Grapevine, Texas, with a branch location in La
Jolla, California, initiated coverage on Cypros Pharmaceutical Corporation (Amex: CYP) with a Buy Recommendation.
RichMark Capital Corporation has issued a 19-page research report, written by research analyst Lynn Trepp, on Cypros
Pharmaceutical Corporation.
Parties interested in receiving copies of the report may contact Peter Foley of RichMark Capital Corporation, in the San Diego
office at (619) 551-7740.
üä RICHMARK CAPITAL CORPORATION
CORPORATE HEADQUARTERS
2133 Stone Moss Lane
Grapevine, Texas 76051
Phone 817-949-1116
Toll Freå8-906-1366
Fax 817-906-1366
SAN DIEGO OFFICE
1200 Prospect Street, Suite 300
La Jolla, California ùÒ7
Phone 619-551-7740
Toll Free 800-922-7740
Fax 619-551-7742
Member NASD/SIPC
SOURCE RichMark Capital Corporation
05/05/99
CONTACT: Peter Foley of RichMark Capital Corporation, 619-551-7740
(CYP) CO: RichMark Capital Corporation; Cypros Pharmaceutical Corporation ST: Califoò Texas IN: FIN SU: RTG
Copyright © 1999, PR Newswire, all rights reserved.
|
